Predicting Recurrence and Progression in NMIBC: A Multi-Event and Temporal Analysis Approach
{{output}}
Objectives: Non-muscle invasive bladder cancer (NMIBC) accounts for 70-80% of all bladder cancer cases. Despite adequate Bacillus Calmette-Guérin (BCG) therapy, approximately 30% of patients fail to respond, with up to 40% recur... ...
